Implanet began a prospective and multicenter clinical study to document outcomes with the JAZZ Band in patients with adult degenerative and deformity conditions.
Here are five key notes:
1. Implanet partnered with TFS International, a professional contract research organization, on the study. TFS will ensure the study is scientifically robust in design and execution.
2. The JAZZ implant treats spinal pathologies with vertebral fusion surgery and has the FDA clearance.
3. Implanet is partnering with spine centers across the United States with expertise in complex adult degenerative surgery and an interest in developing spinal implant technology market.
4. The first scoliosis surgery performed with the JAZZ implant in Brazil occurred earlier this year, after the implant received regulatory approval in the country.
5. Implanet's 2015 annual sales — excluding hip sales which were discontinued — were up 6 percent in 2015 over the previous year. The spine segment grew 45 percent in the fourth quarter.